Stem Cell Alopecia Treatment Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026 – 3rd Watch News

Stem Cell Alopecia Treatment Market Trends, Size, Shares, Growth, Top Companies, Development, Application, Importance, Overview with Detailed Analysis, Production, Supply, Revenue, Regional Outlook, Status, Competitive Landscape, Future Forecast, Type and End-User, Opportunity, Demand, Historical Data, Business Insights, Research Methodology and many more

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Stem Cell Alopecia Treatment Market which would mention How the Covid-19 is Affecting the Stem Cell Alopecia Treatment Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Stem Cell Alopecia Treatment Players to Combat Covid-19 Impact.

Stem Cell Alopecia Treatment research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers, and challenges.

Top Key Players of the Global Stem Cell Alopecia Treatment Market:APEX Biologix, Belgravia Center, Kerastem, Riken Research Institute, RepliCel, Sanford Burnham Prebys Medical Discovery Institute,

Download Full PDF Sample Copy of Stem Cell Alopecia Treatment Report: (Including Full TOC, List of Tables & Figures, Chart) : https://www.qyresearch.com/sample-form/form/1491764/global-stem-cell-alopecia-treatment-market

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Global Stem Cell Alopecia Treatment Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during 2019-2025. According to the latest report added to the online repository of QY Research the Stem Cell Alopecia Treatment market has witnessed an unprecedented growth till 2019. The extrapolated future growth is expected to continue at higher rates by 2025.

Stem Cell Alopecia Treatment Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Get Full Customize report now at: https://www.qyresearch.com/customize-request/form/1491764/global-stem-cell-alopecia-treatment-market

Critical questions addressed by the Stem Cell Alopecia Treatment Market report

What are the key market drivers and restraints?What will be the market size until the end of the forecast period?Which segment is expected to take the lions share?Which region will lead the global Stem Cell Alopecia Treatment market in terms of growth?What will be the key strategies adopted by market leaders in future?What are the upcoming applications?How will the global Stem Cell Alopecia Treatment market develop in the mid to long term?

Table of Contents

1 Stem Cell Alopecia Treatment Market Overview1.1 Stem Cell Alopecia Treatment Product Overview1.2 Stem Cell Alopecia Treatment Market Segment by Type1.2.1 Cloud Service Orchestration1.2.2 API Management1.2.3 Application Integration1.2.4 B2B and Cloud Integration1.2.5 Data Integration1.3 Global Stem Cell Alopecia Treatment Market Size by Type1.3.1 Global Stem Cell Alopecia Treatment Sales and Growth by Type1.3.2 Global Stem Cell Alopecia Treatment Sales and Market Share by Type (2014-2019)1.3.3 Global Stem Cell Alopecia Treatment Revenue and Market Share by Type (2014-2019)1.3.4 Global Stem Cell Alopecia Treatment Price by Type (2014-2019)

2 Global Stem Cell Alopecia Treatment Market Competition by Company2.1 Global Stem Cell Alopecia Treatment Sales and Market Share by Company (2014-2019)2.2 Global Stem Cell Alopecia Treatment Revenue and Share by Company (2014-2019)2.3 Global Stem Cell Alopecia Treatment Price by Company (2014-2019)2.4 Global Top Players Stem Cell Alopecia Treatment Manufacturing Base Distribution, Sales Area, Product Types2.5 Stem Cell Alopecia Treatment Market Competitive Situation and Trends2.5.1 Stem Cell Alopecia Treatment Market Concentration Rate2.5.2 Global Stem Cell Alopecia Treatment Market Share of Top 5 and Top 10 Players2.5.3 Mergers & Acquisitions, Expansion

3 Stem Cell Alopecia Treatment Company Profiles and Sales Data3.1 IBM3.1.1 Company Basic Information, Manufacturing Base and Competitors3.1.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.1.3 IBM Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.1.4 Main Business Overview3.2 Microsoft3.2.1 Company Basic Information, Manufacturing Base and Competitors3.2.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.2.3 Microsoft Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.2.4 Main Business Overview3.3 Oracle3.3.1 Company Basic Information, Manufacturing Base and Competitors3.3.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.3.3 Oracle Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.3.4 Main Business Overview3.4 Software3.4.1 Company Basic Information, Manufacturing Base and Competitors3.4.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.4.3 Software Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.4.4 Main Business Overview3.5 TIBCO Software3.5.1 Company Basic Information, Manufacturing Base and Competitors3.5.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.5.3 TIBCO Software Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.5.4 Main Business Overview3.6 Accenture3.6.1 Company Basic Information, Manufacturing Base and Competitors3.6.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.6.3 Accenture Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.6.4 Main Business Overview3.7 Adeptia3.7.1 Company Basic Information, Manufacturing Base and Competitors3.7.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.7.3 Adeptia Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.7.4 Main Business Overview3.8 Atos3.8.1 Company Basic Information, Manufacturing Base and Competitors3.8.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.8.3 Atos Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.8.4 Main Business Overview3.9 Axway3.9.1 Company Basic Information, Manufacturing Base and Competitors3.9.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.9.3 Axway Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.9.4 Main Business Overview3.10 BT Global Services3.10.1 Company Basic Information, Manufacturing Base and Competitors3.10.2 Stem Cell Alopecia Treatment Product Category, Application and Specification3.10.3 BT Global Services Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin(2014-2019)3.10.4 Main Business Overview

4 Stem Cell Alopecia Treatment Market Status and Outlook by Regions4.1 Global Market Status and Outlook by Regions4.1.1 Global Stem Cell Alopecia Treatment Market Size and CAGR by Regions4.1.2 North America4.1.3 Asia-Pacific4.1.4 Europe4.1.5 South America4.1.6 Middle East and Africa4.2 Global Stem Cell Alopecia Treatment Sales and Revenue by Regions4.2.1 Global Stem Cell Alopecia Treatment Sales and Market Share by Regions (2014-2019)4.2.2 Global Stem Cell Alopecia Treatment Revenue and Market Share by Regions (2014-2019)4.2.3 Global Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin (2014-2019)4.3 North America Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin4.3.1 United States4.3.2 Canada4.3.3 Mexico4.4 Europe Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin4.4.1 Germany4.4.2 UK4.4.3 France4.4.4 Italy4.4.5 Russia4.4.6 Turkey4.5 Asia-Pacific Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin4.5.1 China4.5.2 Japan4.5.3 Korea4.5.4 Southeast Asia4.5.4.1 Indonesia4.5.4.2 Thailand4.5.4.3 Malaysia4.5.4.4 Philippines4.5.4.5 Vietnam4.5.5 India4.5.6 Australia4.6 South America Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin4.6.1 Brazil4.7 Middle East and Africa Stem Cell Alopecia Treatment Sales, Revenue, Price and Gross Margin4.7.1 Egypt4.7.2 GCC Countries

5 Stem Cell Alopecia Treatment Application/End Users5.1 Stem Cell Alopecia Treatment Segment by Application5.1.1 Banking, Financial Services, and Insurance5.1.2 Consumer Goods and Retail5.1.3 Education5.1.4 Government and Public Sector5.1.5 Healthcare and Life Sciences5.1.6 Manufacturing5.1.7 Media and Entertainment5.1.8 Telecommunication and Ites5.1.9 Others5.2 Global Stem Cell Alopecia Treatment Product Segment by Application5.2.1 Global Stem Cell Alopecia Treatment Sales by Application5.2.2 Global Stem Cell Alopecia Treatment Sales and Market Share by Application (2014-2019)

6 Global Stem Cell Alopecia Treatment Market Forecast6.1 Global Stem Cell Alopecia Treatment Sales, Revenue Forecast (2019-2025)6.1.1 Global Stem Cell Alopecia Treatment Sales and Growth Rate Forecast (2019-2025)6.1.1 Global Stem Cell Alopecia Treatment Revenue and Growth Rate Forecast (2019-2025)6.2 Global Stem Cell Alopecia Treatment Forecast by Regions6.2.1 North America Stem Cell Alopecia Treatment Sales and Revenue Forecast (2019-2025)6.2.2 Europe Stem Cell Alopecia Treatment Sales and Revenue Forecast (2019-2025)6.2.3 Asia-Pacific Stem Cell Alopecia Treatment Sales and Revenue Forecast (2019-2025)6.2.3.1 China6.2.3.2 Japan6.2.3.3 Korea6.2.3.4 Southeast Asia6.2.3.5 India6.2.3.6 Australia6.2.4 South America Stem Cell Alopecia Treatment Sales and Revenue Forecast (2019-2025)6.2.5 Middle East and Africa Stem Cell Alopecia Treatment Sales and Revenue Forecast (2019-2025)6.2.5.1 Egypt6.2.5.2 GCC Countries6.3 Stem Cell Alopecia Treatment Forecast by Type6.3.1 Global Stem Cell Alopecia Treatment Sales and Revenue Forecast by Type (2019-2025)6.3.2 Cloud Service Orchestration Gowth Forecast6.3.3 API Management Gowth Forecast6.4 Stem Cell Alopecia Treatment Forecast by Application6.4.1 Global Stem Cell Alopecia Treatment Sales Forecast by Application (2019-2025)6.4.2 Global Stem Cell Alopecia Treatment Forecast in Banking, Financial Services, and Insurance6.4.3 Global Stem Cell Alopecia Treatment Forecast in Consumer Goods and Retail

7 Stem Cell Alopecia Treatment Upstream Raw Materials7.1 Stem Cell Alopecia Treatment Key Raw Materials7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price7.1.3 Raw Materials Key Suppliers7.2 Manufacturing Cost Structure7.2.1 Raw Materials7.2.2 Labor Cost7.2.3 Manufacturing Expenses7.3 Stem Cell Alopecia Treatment Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors8.1 Marketing Channel8.1.1 Direct Marketing8.1.2 Indirect Marketing8.1.3 Marketing Channel Development Trend8.2 Distributors8.3 Downstream Customers

9 Research Findings and Conclusion

AppendixMethodology/Research ApproachResearch Programs/DesignMarket Size EstimationMarket Breakdown and Data TriangulationData SourceSecondary SourcesPrimary SourcesDisclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Originally posted here:
Stem Cell Alopecia Treatment Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026 - 3rd Watch News

COVID-19 Impact and Recovery Analysis | Global Cell Isolation Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Becton,…

LONDON--(BUSINESS WIRE)--The global cell isolation market size is expected to grow by USD 9.47 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Moreover, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 21%.

Request for Technavio's latest reports on directly and indirectly impacted markets

Market estimates include pre- and post-COVID-19 impact on the cell isolation market -

Download free sample report

With the spread of COVID-19, a global increase in R&D activities in AR and PB has been observed in the first half of 2020. Researches are being conducted on stem cell therapies to develop mesenchymal stem cell-based therapies. For instance, in March 2020, researchers from the University of North Texas Health Science Center initiated a clinical trial in China on more than 100 COVID-19 patients and administered injections of mesenchymal stem cells. The rise in such R&D activities is increasing the demand for cell isolation products, which will result in the growth of the cell isolation market during the forecast period.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

https://www.technavio.com/report/global-cell-isolation-market-industry-analysis

The market is driven by the increasing prevalence of chronic diseases. In addition, product advances are anticipated to boost the growth of the cell isolation market.

With the growing incidence of chronic diseases globally, the applications of isolated human cells in research, drug development, and clinical trials are increasing. Cell isolation helps study the behavior of cells and their response to diseases and different drugs. Cell isolation tools are used in drug discovery to generate recombinant protein therapeutics, which can treat a variety of chronic diseases. Hence, the rising prevalence of chronic diseases will boost the need for cell-based therapies, which, in turn, will increase the demand for cell isolation tools.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Cell Isolation Companies:

Agilent Technologies Inc.

Agilent Technologies Inc. has business operations under various segments, such as life sciences and applied markets, diagnostics and genomics, and Agilient CrossLab. The company offers various consumables and instruments for cell isolation procedures.

Becton, Dickinson and Co.

Becton, Dickinson and Co. operates its business through various segments, such as BD Medical, BD Life Sciences, and BD Interventional. The company provides consumables and instruments for cell isolation procedures.

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. has business operations under two segments: life science and clinical diagnostics. The company provides consumables and instruments for cell isolation procedures.

Danaher Corp.

Danaher Corp. operates its business through various segments, such as life sciences, diagnostics, and environment & applied solutions. The company provides consumables and instruments for cell isolation procedures.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. has business operations under two segments: pharmaceuticals and diagnostics. The company provides consumables and instruments for cell isolation procedures.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Cell Isolation Market Product Outlook (Revenue, USD bn, 2020-2024)

Cell Isolation Market Geography Outlook (Revenue, USD bn, 2020-2024)

Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View post:
COVID-19 Impact and Recovery Analysis | Global Cell Isolation Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Becton,...

AMC to use stem cell therapy in treating graft-versus-host disease – Korea Biomedical Review

Korean researchers have found a signal transduction system that modulates the treatment of mesenchymal stem cells and immune control functions, opening the way for treating graft-versus-host disease treatment.

Mesenchymal stem cells divide into various cells, have immunomodulatory functions, and are the primary cell sources for stem cell therapy.

Graft-versus-host disease is a fatal disease that leads to death after an allogeneic blood transfusion or bone marrow transplantation. Although there are many clinical trials underway worldwide to treat the symptom, there are no applicable treatments besides alleviating symptoms with high-dose steroids.

The team, led by Professor Shin Dong-myeong of the Department of Biomedical Sciences at Asan Medical Center, discovered that the CREB1 (CAMP responsive element binding protein 1) signaling system activates the treatment and immune control functions of mesenchymal stem cells.

The team administered a therapeutic agent made by upgrading mesenchymal stem cells to graft-versus-host disease mice, and found that it alleviated anorexia symptoms and reduced the weight loss rate by 30 percent while increasing the survival rate by 30 percent.

When developing a cell therapy product, researchers have to cultivate the stem cells in vitro. Thus it is very likely that it will impair stem cell functions due to free radicals generated in the cells. To prevent the deterioration of stem cell function, it is necessary to improve the stem cell function in vitro culture, prevent stem cell oxidation, and increase the antioxidant capacity of the cell itself.

Until now, there was a lack of specific evidence and understanding of how stem cells regulate glutathione, an indicator of antioxidant capacity. Therefore, it was difficult to prevent stem cell dysfunction and oxidation.

Professor Shin's team developed experimental techniques that can monitor and quantify glutathione in real-time and confirmed that the CREB1 signaling system regulated the amount and activity of glutathione.

By activating the CREB1 signaling system, the team found that the process also activated nuclear factor erythroid 2-related factor 2 (NRF2) protein, which maintains the antioxidant capacity of mesenchymal stem cells and the increase of both the expression levels of peroxiredoxin-1 (PRDX1) and glutamate-cysteine ligase modifier subunit (GCLM) protein, which synthesize glutathione and are antioxidant activity indicators.

As a result, the team confirmed that its method was effective in treating the graft-versus-host disease.

"Based on this study, we have secured a technological foundation to advance stem cell treatment by controlling the antioxidant capacity of stem cells," Professor Shin said.

If this technology makes a high-purity and high-quality stem cell treatment, the team expects that it will be a step toward developing a graft-versus-host disease treatment and overcoming various intractable diseases such as nervous system diseases and inflammatory diseases with high medical demand, Shin added.

The results of the study were published in the journal, Science Advances.

corea022@docdocdoc.co.kr

< Korea Biomedical Review, All rights reserved.>

Read the original here:
AMC to use stem cell therapy in treating graft-versus-host disease - Korea Biomedical Review

Drumming class finds a new rhythm with creative connections – Yes! Weekly

Winston-Salem, N.C. When music professor John Becks Afro-Cuban drumming class moved online, his students didnt miss a beat even though only one of the 17 seniors in his class had access to a drum.

The global drum circle community on social media was quick to offer ideas for virtual groups. One video showed a friend of mine drumming on a picnic table and asking people to play his rhythm back, said Beck.

The students first assignment was based on that video.

I assembled their clips together and posted the recording so they could all see each other like we do in class when we are seated in a circle. One week I asked the students to send me their favorite song, and they recorded themselves drumming on buckets, tables, boxes and metal pots.

In an in-person class there is a sense of community, Beck explains. The group works together creating rhythm, smiling and enjoying the experience. But after spending time immersed in the video projects, looking at the student clips, watching them drum and assembling the projects on his computer, he felt he knew this class better than any other he has taught.

Beck recently completed a 22-month study at Wake Forest Baptist Medical Center with stem cell transplant recipients using a protocol developed called Comfort Sound drumming. During the patient drumming experience, researchers identified improvement in mood, energy and relaxation, and decreases in anxiety, distress and pain.

The video compilations were a way of being together through the music and my students expressed they felt similar benefits to the ones in our study. Our work together helped them cope with the stress of finishing their time at Wake Forest away from their friends and teachers.

Senior Lizzie Pittinger, a political science major, said continuing with the drumming exercises online was not only a fun way to stay connected with her classmates, but also created a sense of normalcy during this uncertain time. Despite the physical distance that I felt from my classmates as we were all learning from our own homes, the weekly assignments reminded me that we will always be able to connect by sharing experiences with each othereven if it has to be through Zoom for now!

Watch the video here.

###

About Wake Forest University:

Wake Forest University combines the best traditions of a small liberal arts college with the resources of a large research university. Founded in 1834, the school is located in Winston-Salem, N.C. The Universitys graduate school of arts and sciences, divinity school, and nationally ranked schools of law, medicine and business enrich our intellectual environment. Learn more about Wake Forest University at http://www.wfu.edu.

See the original post here:
Drumming class finds a new rhythm with creative connections - Yes! Weekly

Drumming class finds a new rhythm with creative connections – Wake Forest University News Center

When music professor John Becks Afro-Cuban drumming class moved online, his students didnt miss a beat even though only one of the 17 seniors in his class had access to a drum.

The global drum circle community on social media was quick to offer ideas for virtual groups. One video showed a friend of mine drumming on a picnic table and asking people to play his rhythm back, said Beck.

The students first assignment was based on that video.

I assembled their clips together and posted the recording so they could all see each other like we do in class when we are seated in a circle. One week I asked the students to send me their favorite song, and they recorded themselves drumming on buckets, tables, boxes and metal pots.

In an in-person class there is a sense of community, Beck explains. The group works together creating rhythm, smiling and enjoying the experience. But after spending time immersed in the video projects, looking at the student clips, watching them drum and assembling the projects on his computer, he felt he knew this class better than any other he has taught.

Beck recently completed a 22-month study at Wake Forest Baptist Medical Center with stem cell transplant recipients using a protocol developed called Comfort Sound Drumming. During the patient drumming experience, researchers identified improvement in mood, energy and relaxation, and decreases in anxiety, distress and pain.

Follow this link:
Drumming class finds a new rhythm with creative connections - Wake Forest University News Center

Insights on the Worldwide Cell Expansion Industry to 2027 – Analysis and Forecasts – Yahoo Finance UK

Dublin, May 05, 2020 (GLOBE NEWSWIRE) -- The "Cell Expansion Market to 2027 - Global Analysis and Forecasts By Product; Cell Type; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market is projected to reach US$ 42,837.11 Mn in 2027 from US$ 11,929.43 Mn in 2018. The cell expansion market is expected to grow with a CAGR of 15.6% from 2019-2027.

Driving factors include increasing adoption of regenerative medicines, rising prevalence of cancer. However, the risk contamination during cell expansion is expected to hamper the market during the forecast period.

Cancer is one of the major cause of human death worldwide. In recent years, the cases of cancer have been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.

Changes in lifestyle have resulted in more exposure to oncogenic factors. Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, cell expansion related procedures also aids in research, diagnostics and treatment of cancer.

Furthermore, Asia Pacific region is also facing the problem of the growing prevalence of cancer. The top 15 countries with Cancer prevalence are Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia. According to the National Institute of Cancer Prevention and Research (NICPR), in 2018, in India, total deaths due to cancer were 784,821.

The global Cell Expansion market is segmented by product, cell type, application, end user. Based on product, the cell expansion market is segmented into consumables and instruments. In 2018, the consumables accounted for the largest market share in the global cell expansion market by product. These consumables are essential components of any laboratory experiment hence they are expected to witness significant growth during the forecast period. Based on cell type, the cell expansion market has been segmented into human cell and animal cell. Furthermore based on application the cell expansion market has been segmented into Regenerative Medicine And Stem Cell Research, Cancer And Cell-Based Research and Other Applications. Based in end user market is segmented into Biopharmaceutical And Biotechnology Companies, Research Institutes, cell banks and others.

Some of the essential primary and secondary sources included in the report are the National Institute of Cancer Prevention and Research (NICPR), Association for Management Education and Development, Center for Cancer Research, International Society for Stem Cell Research (ISSCR), American Association of Blood Banks (AABB), National Institute of Cancer Prevention and Research and others.

Reasons to Buy

Key Topics Covered:

1. Introduction

2. Cell Expansion Market - Key Takeaways

3. Research Methodology

4. Cell Expansion- Market Landscape4.1 Overview4.2 PEST Analysis4.3 Expert Opinions

5. Global Cell Expansion Market - Key Market Dynamics5.1 Key Market Drivers5.1.1 Increasing Adoption of Regenerative Medicines5.1.2 Rising Prevalence of Cancer5.2 Key Restraints5.2.1 Risk Contamination During Cell Expansion5.3 Key Opportunity5.3.1 Middle Income Countries Creating Development Opportunities5.4 Future Trend5.4.1 Consistent Research in Drug Discovery Activities5.5 Impact Analysis

6. Cell Expansion Market - Global Analysis6.1 Global Cell Expansion Market Revenue Forecasts And Analysis6.2 Global Cell Expansion Market, By Geography - Forecasts And Analysis6.3 Market Positioning Of Key Players

7. Cell Expansion Market - Revenue And Forecasts To 2027 - Product7.1 Overview7.2 Global Cell Expansion Market, by Product , 2018 & 2027 (% Share)7.3 Consumables7.3.1 Overview7.3.2 Global Consumables Market Revenue and Forecast to 2027 (US$ Mn)7.3.3 Reagents, Media & Serum7.3.3.1 Overview7.3.3.2 Global Reagents, Media & Serum Market Revenue and Forecast to 2027 (US$ Mn)7.3.4 Disposables7.3.4.1 Overview7.3.4.2 Global Disposables Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.3 Culture Tissue Flasks7.3.4.3.1 Overview7.3.4.3.2 Global Culture Tissue Flasks Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.4 Bioreactor Accessories7.3.4.4.1 Overview7.3.4.4.2 Global Bioreactor Accessories Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.5 Other Disposables7.3.4.5.1 Overview7.3.4.5.2 Global Other Disposables Market Revenue and Forecast to 2027 (US$ Mn)7.4 Instruments7.4.1 Overview7.4.2 Global Instruments Market Revenue and Forecast to 2027 (US$ Mn)7.4.3 Cell Expansion Supporting Equipment7.4.3.1 Overview7.4.3.2 Global Cell Expansion Supporting Equipment Market Revenue and Forecast to 2027 (US$ Mn)7.4.4 Bioreactors7.4.4.1 Overview7.4.4.2 Global Bioreactors Market Revenue and Forecast to 2027 (US$ Mn)7.4.5 Automated Cell Expansion Systems7.4.5.1 Overview7.4.5.2 Global Automated Cell Expansion Systems Market Revenue and Forecast to 2027 (US$ Mn)

8. Cell Expansion Market Analysis and Forecasts to 2027 - Cell Type8.1 Overview8.2 Global Cell Expansion Market, by Cell Type, 2018 & 2027 (% Share)8.3 Human Cells8.3.1 Overview8.3.2 Global Human Cell Market Revenue and Forecast to 2027 (US$ Mn)8.3.3 Adult Stem Cells8.3.3.1 Overview8.3.3.2 Global Adult Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.4 Induced Pluripotent Stem Cells8.3.4.1 Overview8.3.4.2 Global Induced Pluripotent Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.5 Embryonic Stem Cells8.3.5.1 Overview8.3.5.2 Global Embryonic Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.6 Differentiated Cells8.3.6.1 Overview8.3.6.2 Global Differentiated Cells Market Revenue and Forecast to 2027 (US$ Mn)8.4 Animal Cells8.4.1 Overview8.4.2 Global Animal Cell Market Revenue and Forecast to 2027 (US$ Mn)

9. Cell Expansion Market Analysis And Forecasts To 2027 - Application9.1 Overview9.2 Global Cell Expansion Market Share by Application 2018 & 2027 (%)9.3 Regenerative Medicine And Stem Cell Research9.3.1 Overview9.3.2 Global Regenerative Medicine And Stem Cell Research Market Revenue and Forecast to 2027 (US$ Mn)9.4 Cancer And Cell-Based Research9.4.1 Overview9.4.2 Global Cancer And Cell-Based research Market Revenue and Forecast to 2027 (US$ Mn)9.5 Other Applications9.5.1 Overview9.5.2 Global Other Applications Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Expansion Market Analysis And Forecasts To 2027 - End User10.1 Overview10.2 Global Cell Expansion Market Share by End User 2018 & 2027 (%)10.3 Biopharmaceutical And Biotechnology Companies10.3.1 Overview10.3.2 Global Biopharmaceutical And Biotechnology Companies Market Revenue and Forecast to 2027 (US$ Mn)10.4 Research Institutes10.4.1 Overview10.4.2 Global Research Institutes Market Revenue and Forecast to 2027 (US$ Mn)10.5 Cell Banks10.5.1 Overview10.5.2 Global Cell Banks Market Revenue and Forecast to 2027 (US$ Mn)10.6 Other End Users10.6.1 Overview10.6.2 Global Other End Users Market Revenue and Forecast to 2027 (US$ Mn)

11. Cell Expansion Market - Geographic Analysis11.1 North America Cell Expansion Market, Revenue and Forecast to 202711.2 Europe Cell Expansion Market, Revenue and Forecast to 202711.3 APAC Cell Expansion Market, Revenue and Forecast to 202711.4 MEA Cell Expansion Market, Revenue and Forecast to 202711.5 South and Central America Cell Expansion Market, Revenue and Forecast to 2027

12. Cell Expansion Market - Industry Landscape12.1 Overview12.2 Growth Strategies In The Cell Expansion Market, 2017-201912.3 Organic Growth Strategies12.3.1 Overview12.3.1.1 Recent Organic Developments By Players In The Cell Expansion Market12.4 Inorganic Growth Strategies12.4.1 Overview12.4.2 Recent Developments By Players In The Cell Expansion Market

13. Global Cell Expansion Market-Key Company Profiles13.1 BD13.1.1 Key Facts13.1.2 Business Description13.1.3 Financial Overview13.1.4 Product Portfolio13.1.5 SWOT Analysis13.1.6 Key Developments13.2 Merck KGaA13.3 Thermo Fisher Scientific, Inc.13.4 Terumo Corporation13.5 General Electric Company13.6 Corning Incorporated13.7 Miltenyi Biotec13.8 Danaher13.9 Lonza13.10 STEMCELL Technologies, Inc.

14. Appendix14.1 About the Publisher14.2 Glossary Of Terms

For more information about this report visit https://www.researchandmarkets.com/r/hjxwqh

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read the original post:
Insights on the Worldwide Cell Expansion Industry to 2027 - Analysis and Forecasts - Yahoo Finance UK

These 5 Houston-area research institutions have bright minds at work to battle COVID-19 – InnovationMap

Since even the early days of COVID-19's existence, researchers all over the world were rallying to find a cure or potential vaccine which usually take years to make, test, and get approved.

Houston researchers were among this group to put their thinking caps on to come up with solutions to the many problems of the coronavirus. From the testing of existing drugs to tapping into tech to map the disease, here are some research projects that are happening in Houston and are emerging to fight the pandemic.

Baylor College of Medicine has identified a drug that could potentially help heal COVID-19 patients. Photo via bcm.edu

While Baylor College of Medicine has professionals attacking COVID-19 from all angles, one recent discovery at BCM includes a new drug for treating COVID-caused pneumonia.

BCM researchers are looking into Tocilizumab's (TCZ), an immunomodulator drug, effect on patients at Baylor St. Luke's Medical Center and Harris Health System's Ben Taub Hospital.

"The organ most commonly affected by COVID-19 is the lung, causing pneumonia for some patients and leading to difficulty breathing," says Dr. Ivan O. Rosas, chief of the pulmonary, critical care and sleep medicine section at BCM, in a news release.

TCZ, which has been used to successfully treat hyperimmune responses in cancer patients being treated with immunotherapy, targets the immune response to the coronavirus. It isn't expected to get rid of the virus, but hopefully will reduce the "cytokine storm," which is described as "the hyper-immune response triggered by the viral pneumonia" in the release.

The randomized clinical trial is looking to treat 330 participants and estimates completion of enrollment early next month and is sponsored by Genentech, a biotechnology company.

A Texas A&M University researcher is trying to figure out if an existing vaccine has an effect on COVID-19. Screenshot via youtube.com

A researcher from Texas A&M University is working with his colleagues on a short-term response to COVID-19. A vaccine, called BDG, has already been deemed safe and used for treatment for bladder cancer. BDG can work to strengthen the immune system.

"It's not going to prevent people from getting infected," says Dr. Jeffrey D. Cirillo, a Regent's Professor of Microbial Pathogenesis and Immunology at the Texas A&M Health Science Center, in a news release. "This vaccine has the very broad ability to strengthen your immune response. We call it 'trained immunity.'"

A&M leads the study in partnership with the University of Texas MD Anderson Cancer Center and Baylor College of Medicine in Houston, as well as Harvard University's School of Public Health and Cedars Sinai Medical Center in Los Angeles.

Texas A&M Chancellor John Sharp last week set aside $2.5 million from the Chancellor's Research Initiative for the study. This has freed up Cirillo's team's time that was previously being used to apply for grants.

"If there was ever a time to invest in medical research, it is now," Sharp says in the release. "Dr. Cirillo has a head start on a possible coronavirus treatment, and I want to make sure he has what he needs to protect the world from more of the horrible effects of this pandemic."

Currently, the research team is recruiting 1,800 volunteers for the trial that is already underway in College Station and Houston with the potential for expansion in Los Angeles and Boston. Medical professionals interested in the trial can contact Gabriel Neal, MD at gneal@tamu.edu or Jeffrey Cirillo, PhD at jdcirillo@tamu.edu or George Udeani, PharmD DSc at udeani@tamu.edu.

"This could make a huge difference in the next two to three years while the development of a specific vaccine is developed for COVID-19," Cirillo says in the release.

Researchers at Rice University's Center for Research Computing's Spatial Studies Lab have mapped out all cases of COVID-19 across Texas by tapping into public health data. The map, which is accessible at coronavirusintexas.org, also identifies the number of people tested across the state, hospital bed utilization rate, and more.

The project is led by Fars el-Dahdah, director of Rice's Humanities Research Center. El-Dahdah used open source code made available by ESRI and data from the Texas Department of State Health Services and Definitive Healthcare.

"Now that the Texas Division of Emergency Management released its own GIS hub, our dashboard will move away from duplicating information in order to correlate other numbers such as those of available beds and the potential for increasing the number of beds in relation to the location of available COVID providers," el-Dahdah says in a press release.

"We're now adding another layer, which is the number of available nurses," el-Dahdah continues. "Because if this explodes, as a doctor friend recently told me, we could be running out of nurses before running out of beds."

A new compound being developed at Texas Heart Institute could revolutionize the effect of vaccines. Photo via texasheart.org

Molecular technology coming out of the Texas Heart Institute and 7 HIlls Pharma could make vaccines like a potential coronavirus vaccine more effective. The oral integrin activator has been licensed to 7 Hills and is slated to a part of a Phase 1 healthy volunteer study to support solid tumor and infectious disease indications in the fall, according to a press release.

The program is led by Dr. Peter Vanderslice, director of biology at the Molecular Cardiology Research Laboratory at Texas Heart Institute. The compound was first envisioned to improve stem cell therapy for potential use as an immunotherapeutic for certain cancers.

"Our research and clinical colleagues are working diligently every day to advance promising discoveries for at risk patients," says Dr. Darren Woodside, co-inventor and vice president for research at the Texas Heart Institute, in the release. "This platform could be an important therapeutic agent for cardiac and cancer patients as well as older individuals at higher risk for infections."

UH researchers have developed a pliable, thin material that can monitor changes in temperature. Photo via uh.edu

While developed prior to the pandemic, nanotechnology out of the University of Houston could be useful in monitoring COVID patients' temperatures. The material, as described in a paper published by ACS Applied Nano Materials, is made up of carbon nanotubes and can indicate slight body temperature changes. It's thin and pliable, making it ideal for a wearable health tech device.

"Your body can tell you something is wrong before it becomes obvious," says Seamus Curran, a physics professor at the University of Houston and co-author on the paper, in a news release.

Curran's nanotechnology research with fellow researchers Kang-Shyang Liao and Alexander J. Wang, which also has applications in making particle-blocking face masks, began almost 10 years ago.

See original here:
These 5 Houston-area research institutions have bright minds at work to battle COVID-19 - InnovationMap

GCC Condemns Israeli Plans to Annex Parts of the West Bank – Asharq Al-awsat English

Secretary-General of the Gulf Cooperation Council Dr. Nayef Falah Mubarak Al-Hajraf stressed the importance of the Council of the Arab League resolution, issued at their meeting at the ministerial level in its extraordinary session on Thursday, condemning the Israeli occupation authorities' implementation of plans to annex any part of the Palestinian territories.

He affirmed the position of the Gulf Cooperation Council on the Palestinian cause as the first Arab and Muslim issue, expressing support for the permanent sovereignty of the Palestinian people over all their territories occupied since June 1967.

Hajraf also stressed support for the establishment of an independent Palestinian state with East Jerusalem as its capital, and the necessity of activating the efforts of the international community to resolve the conflict.

He noted that the Israeli decision to annex Palestinian territories occupied in 1967, including the Jordan Valley, the northern Dead Sea, and the lands on which Israeli settlements are located and their surroundings, is a grave breach of the Charter and the resolutions of the United Nations and the principles of international law that prohibits the disposal or annexation of occupied territories

Hajraf also slammed all Israeli policies and practices against the Palestinian people and their sanctities, including what is taking place in occupied East Jerusalem, the recent Israeli aggression aimed at controlling Islamic Waqf lands around the Ibrahim Sanctuary in the occupied Hebron city, and the blockade of the Gaza Strip.

See the rest here:
GCC Condemns Israeli Plans to Annex Parts of the West Bank - Asharq Al-awsat English

Jerusalem residents concerned Israel is changing their residency rights – Arabnews

AMMAN: Palestinian residents of Jerusalem, as well as Syrian residents of the occupied Golan Heights, are complaining that they are facing unprecedented discrimination when traveling home to Israel due to the fact that they dont have Israeli citizenship.

Residents of occupied Jerusalem and the Golan, which were annexed by Israel in 1967 and 1981, have complained that they are being denied the right to board planes to return home without an special ishur (permit).

They have been told that this permit has to be obtained from Israeli embassies or the Israeli Foreign Ministry.

Munir Nuseibah, director of the Community Action Center at Al-Quds University, confirmed the problem and told Arab News that complaints were coming in to the center about Jerusalemites running into problems at airports.

The complaints are very worrisome. It is scary to learn of new Israeli procedures that change what we have been used to for decades.

Khader Abu Alia, an English language teacher at Al-Quds University, told his colleagues at the university that he was barred from entering the country.

He sent a message to members of the Israeli Knesset saying he had needed to travel in mid-March to the US, and that when he boarded the return flight on April 14 he was told that he was not allowed in upon arriving at Ben Gurion Airport passport control, because he didnt have an Israeli passport.

Students trying to board an Israel Airlines flight from Moscow on April 24 were barred and told that only individuals holding Israeli passports would be allowed to travel to Israel.

The problem was later resolved and the students were allowed to travel.

Another problem occurred when students, including from Jerusalem and the Golan Heights, tried and failed to board a plane from Turkey to Israel, and needed the intervention of Arab members of the Knesset before they were allowed to travel back home.

Nuseibah told Arab News that it was unclear if there were any new regulations or if this problem was as a result of the coronavirus pandemic, or if the virus was being used as a cover to pass-through new discriminatory laws.

We have prepared legal action to challenge this new regulation but decided to hold off on this until we find out whether the problems that have been faced by returning Jerusalemites is a one-off bureaucratic problem or a new policy change.

Nuseibah told Arab News that they had contacted Ahmad Tibi, the Israeli Arab member of the Knesset, who reassured him that there had been no change in policy.

We will continue to monitor the situation and check with the Ministry of Interior and the Foreign Ministry before deciding whether there is indeed policy change or not.

If we reach the conclusion that there is a policy change, we will go ahead with the lawsuit that the new policy is a discriminatory one.

Nuseibah concluded that Jerusalemites did not go to Israel but Israel came to Jerusalem and therefore the people of the city have a right to travel and return without any discriminatory regulations.

See original here:
Jerusalem residents concerned Israel is changing their residency rights - Arabnews

Four UTSW Researchers Named to The National Academy of Sciences – D Magazine

Four UT Southwestern Medical Center scientists have been elected to the The National Academy of Sciences, one of the top honors for American scientists.

Peer scientists selected Sean Morrison, Kim Orth, Michael Rosen, and Sandra Schmid for their original research and achievements. UT Southwestern now has 25 members of the academy, the most of any institution in Texas.

Election to the prestigious National Academy of Sciences recognizes the pioneering contributions these scientists have made to advance our understanding of basic cellular function and molecular processes with application to addressing a broad spectrum of unmet medical needs including cancer and treatments for bacterial infections, said Dr. Daniel K. Podolsky, President of UT Southwestern Medical Center via release. Their election enriches the National Academy of Sciences efforts to provide data and advice on the nations most critical issues in science, health, and medicine.

Morrison is the Director of the Childrens Medical Center Research Institute (CRI) at UT Southwestern and Professor of Pediatrics and has worked in the fields of stem cell biology and cancer, and has created new methods to purify stem cells and allow them to persist and regenerate after injury. This recognizes, first and foremost, the work of many talented people over the years in my lab, most of whom have now gone on to their own laboratories at UT Southwestern and other institutions. Many of the key insights for the important discoveries that were made came from them so this really recognizes their work. Id also like to acknowledge all my colleagues, all of you at UT Southwestern and at Childrens Health, for the incredible environment that you created for science, Morrison said via release.

Orth is a Professor of Molecular Biology and Biochemistry and has discovered biochemical mechanisms behind many bacterial infections, revealing how pathogens use host cells for their own benefit. I want to thank you all for this wonderful celebration, even though we have to Zoom . Thanks to this amazing institution, UT Southwestern, the wonderful administration including Drs. (Daniel) Podolsky and (David) Russell and the other administrators and staff. As (Chair of Molecular Biology) Eric Olson said, I have moved up the ranks here, starting as a technician, to a student, a postdoc, and now Professor, Orth said via release. And this path has driven my success. Another major key to my success is all of the talented people that have worked in my lab and my mentors, friends, collaborators, and, of course, my family.

Rosen is the Chair of Biophysics and Professor in the Cecil H. and Ida Green Comprehensive Center for Molecular, Computational, and Systems Biology, and investigates how cells compartmentalize processes without the use of membranes. When we began our work on phase separation about a decade ago, it really was not obvious at all whether this was going to be some weird, esoteric little thing that a few proteins did or (if) it was going to become a more general principle in biology. So it wasa tremendous risk that many of us took in making a move in this new direction. More than anything, I want to thank the various people whojoined me in taking this great risk a decade ago that I think has proved to be very much worthwhile, Rosen said via release.

Schmid is the Professor and Chair of Cell Biology and is recognized for her work on endocytosis, or how cells absorb nutrients and other molecules, including the major pathway for uptake within the cell. Ive been lucky to start and end my academic career at two unique institutions, Schmid said via release. As a PhD student in the early 80s, I was supported and challenged by my peers and faculty in the Biochemistry department at Stanford to ask important questions and do the most impactful research. Over decades, the leadership at UT Southwestern has inspired, supported and celebrated the very best research creating a collegial culture that breeds success.

This important recognition by their peers reflects the breadth and quality of research underway at UT Southwestern, and serves as inspiration for new generations of trainees and scientists to carry on the tradition of discovery that is the hallmark of distinguished academic medical centers, said Dr. W. P. Andrew Lee., Executive Vice President for Academic Affairs, Provost and Dean of UT Southwestern Medical School via release.

See the article here:
Four UTSW Researchers Named to The National Academy of Sciences - D Magazine